Engineered extracellular vesicles halt lung cancer growth by silencing key protein

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie ...
MedPage Today

FDA Approves Maintenance Combo for Small Cell Lung Cancer

The FDA approved lurbinectedin (Zepzelca) plus either atezolizumab (Tecentriq) or atezolizumab and hyaluronidase (Tecentriq Hybreza) as first-line maintenance therapy for extensive-stage small cell ...
IEEE

Intelligent Data Classification and Computer Vision model-based Breast Cancer Image Processing Using Digital Mammography

Abstract: Breast cancer poses a global health challenge for women, making early detection and precise classification crucial for successful treatment. The study presents Intelligent Data ...
SciTech Daily

Breakthrough Blood Test Detects Head and Neck Cancer up to 10 Years Before Symptoms

A novel blood test, HPV-DeepSeek, shows it can reveal head and neck cancers linked to HPV up to 10 years before symptoms arise. The findings hint at a future where these cancers could be treated far ...
ascopubs.org

Real-World Outcomes in Anaplastic Lymphoma Kinase–Positive Advanced Non–Small Cell Lung Cancer in Argentina: A Multicenter Retrospective Study (GAOT-ALK001)

Implementation of Real-World Diagnostic Strategies in Taiwan for the Identification of Targetable Oncogenic Driver Alterations in Non–Small Cell Lung Cancer We conducted a multicenter retrospective ...
Reuters

Jazz Pharma, Roche's combination therapy for lung cancer gets US approval

Oct 2 (Reuters) - The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals (JAZZ.O), opens new tab and Roche's (ROG.S), opens new tab combination therapy as a maintenance treatment for ...